Anesth Analg 2005;101:785-792
© 2005 International Anesthesia Research Society
doi: 10.1213/01.ane.0000166978.12457.7a
PAIN MEDICINE
Novel Depots of Ketorolac Esters Have Long-Acting Antinociceptive and Antiinflammatory Effects
Shyun-Yeu Liu, DDS* ,
Ja-Ping Shieh, MD, MS ,
Jann-Inn Tzeng, MD, MS ,
Hou Chia-Hui, BS ,
Yen-Ling Cheng, BS ,
Kuo-Lun Huang, MS , and
Jhi-Joung Wang, MD, PhD
*Department of Oral and Maxillofacial Surgery, National Defense Medical Center, Taipei; Department of Oral and Maxillofacial Surgery, Taipei Medical University, Taipei; and Departments of Anesthesiology and Medical Research, Chi-Mei Medical Center, Tainan (Yung-Kang and Liou-Ying), Taiwan
Address correspondence and reprint requests to Jhi-Joung Wang, MD, PhD, Departments of Anesthesiology and Medical Research, Chi-Mei Medical Center, Tainan, Taiwan. Address e-mail to 400002{at}mail.chimei.org.tw.
No long-acting nonsteroidal antiinflammatory drug is clinically available for the treatment of pain. In this study, we evaluated the antinociceptive and antiinflammatory effects and duration of action of several novel depots of ketorolac esters, such as ketorolac propyl ester, pentyl ester, heptyl ester, and decyl ester, and observed whether they had a long-acting effect. Four studies in Sprague-Dawley rats were performed. In Studies 13, the antinociceptive and antiinflammatory effects of IM ketorolac tromethamine and its base and propyl ester were evaluated. In Study 4, the antinociceptive and antiinflammatory effects of several other ketorolac esters were evaluated. We found that ketorolac tromethamine 24, 80, and 240 µmol/kg (in saline) produced significant antinociceptive and antiinflammatory effects with duration of action of approximately 68 h. The four ketorolac esters at a dose of 240 µmol/kg (in oil) produced significant long-acting antinociceptive and antiinflammatory effects, with duration of action of approximately 5276 h. We concluded that IM injection of novel depots of ketorolac esters in rats produce long-acting antinociceptive and antiinflammatory effects that are 6.5- to 9.5-fold longer than the traditional dosage form of ketorolac tromethamine.
|